CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer
Titel:
CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer
Auteur:
Aleksakhina, S. N. Kramchaninov, M. M. Mikushina, A. D. Kubrina, S. E. Petkau, V. V. Ivantsov, A. O. Moiseyenko, V. M. Imyanitov, E. N. Iyevleva, A. G.